<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26312706</article-id>
      <article-id pub-id-type="pmc">4540540</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153406</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The role of immunohistochemistry in the Muir-Torre Syndrome<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Cl&#xE1;udia Marina Puga Barbosa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Campos</surname>
            <given-names>Jullyene Gomes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maia</surname>
            <given-names>Maiko Ramacos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lobo</surname>
            <given-names>Larissa Eva dos Santos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>do Valle</surname>
            <given-names>F&#xE1;bio Francesconi</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <aff id="aff01"><label>1</label>Universidade Federal do Amazonas (UFAM) - Manaus (AM),
Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Cl&#xE1;udia Marina Puga Barbosa Oliveira, Rua A, 44 -
Conjunto Aristocr&#xE1;tico, Chapada, 69050-130 - Manaus - AM, Brazil. E-mail:
<email>claudiamarinapuga@hotmail.com</email></corresp>
        <fn fn-type="conflict">
          <p>Conflict of Interest: None.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>3 Suppl 1</issue>
      <fpage>168</fpage>
      <lpage>170</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Muir-Torre Syndrome is defined by the coexistence of sebaceous skin tumors and
internal malignancies. Mutations in the DNA mismatch repair genes are found in the
inherited form of the disease, resulting in the absence of crucial enzymes involved
with DNA replication process. This case describes a patient with sebaceous adenoma
and colorectal carcinoma, meeting the criteria for Muir-Torre Syndrome. The
immunohistochemical analysis of the skin lesion was an important tool to confirm the
diagnosis, as it revealed nuclear negativity for MSH2 and MSH6.</p>
      </abstract>
      <kwd-group>
        <kwd>Adenoma</kwd>
        <kwd>Colorectal Neoplasms</kwd>
        <kwd>DNA Repair</kwd>
        <kwd>Muir-Torre Syndrome</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Described by Muir <italic>et al</italic> and Torre, Muir-Torre Syndrome (MTS) is a rare
autosomal dominant condition with a high degree of penetrance.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup> In 1995,
diagnostic criteria for the syndrome were proposed by Schwartz and Torre, which included
the presence of a sebaceous tumor (sebaceous adenoma, sebaceous carcinoma or sebaceoma)
and at least one visceral malignancy.<sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>Currently, it is believed that there are two types of MTS. The most common form is a
variant of Hereditary Nonpolyposis Colorectal Cancer or Lynch Syndrome, associated with
germline mutations in DNA repair genes encoders of proteins <italic>MutL Homolog 1
(MLH1)</italic> and <italic>MutS Homolog 2 (MSH2)</italic>. Recently, mutations in
genes of proteins <italic>MutS Homolog 6 (MSH6)</italic> and <italic>Postmeiotic
Segregation Increased 2 (PMS2)</italic> were also implicated. The other spectrum of
the disease, however, has no correlation with family history and seems to involve other
genes than the DNA repairing ones.<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>In this article, the authors report the case of a male patient with multiple sebaceous
tumors and history of colorectal carcinoma. The immunohistochemical study of the
cutaneous neoplasm was used to corroborate the diagnosis of Muir-Torre Syndrome,
revealing the expected negativity for DNA repair enzymes.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Male patient, 41 years old, presented at the Dermatology service complaining about the
onset of multiple yellowish papules with central umbilication located on the face (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>). The anatomopathological examination was conclusive for sebaceous adenoma
(<xref ref-type="fig" rid="f03">Figure 3</xref>). An immunohistochemical study was
performed through a standard technique, with parts (sugest&#xE3;o: tissue pieces) in paraffin
blocks and histological sections incubated with a panel of monoclonal antibodies. A
polymer-based detection system was used. The antibodies used were repair enzymes
<italic>MSH2</italic>, <italic>MSH6</italic> and <italic>MLH1,</italic> with nuclear
negativity occurring for <italic>MSH2</italic> and <italic>MSH6</italic> and
inconclusive <italic>MLH1</italic> search (<xref ref-type="fig" rid="f04">Figures
4</xref> and <xref ref-type="fig" rid="f05">5</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Sebaceous adenomas on the face of patient with Muir-Torre Syndrome</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0168-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Detail of papular lesions on the face</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0168-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Anatomopathological examination: sebaceous adenoma</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0168-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Immunohistochemical examination: sebaceous adenoma revealing nuclear negativity
for repair enzyme MSH2</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0168-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Immunohistochemical examination: sebaceous adenoma in a positive control patient
showing preserved nuclear reactivity for repair enzyme MLH1</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0168-g05"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The most frequent MTS subtype is the phenotypic spectrum of Lynch syndrome, in which
mutations of DNA repair genes can be detected.</p>
      <p>The DNA repairing system is critically important to maintain genome stability during DNA
replication. Failure in this process results in mutation of genetic material and
microsatellite instability. For example, the loss of expression of the protein coded by
gene <italic>MSH2</italic> leads to the accumulation of replication errors, which
ultimately is related to tumor susceptibility. <sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r07" ref-type="bibr">7</xref></sup></p>
      <p>MTS mutations predispose for the onset of cutaneous tumors of sebaceous origin.
Notwithstanding, the mechanism through which the loss of repairing proteins and
microsatellite instability result in this type of tumor has not yet been
elucidated.<sup><xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>In general, sebaceous tumors are rare in the population, and for this reason their onset
represents an important marker for investigation of the syndrome.<sup><xref rid="r09" ref-type="bibr">9</xref></sup> The most frequently found cutaneous
neoplasms are sebaceous adenoma, sebaceous carcinoma and sebaceoma, which are usually
subsequent to the diagnosis of visceral carcinoma in 56% of the cases. Keratoacanthomas
and non-melanoma skin carcinomas are also described with sebaceous differentiation in
the carriers of the disease.<sup><xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>As to visceral neoplasms, colorectal carcinomas account for 51% of the cases.
Malignancies of the genitourinary system, breast, lungs, parotid gland, upper
gastrointestinal tract, larynx and blood may be present, although rarely. The follow-up
of these patients is comprised of colonoscopy every 3-5 years, starting at 25-30 years
of age, cystoscopy and intravenous pyelogram at regular intervals, computed tomography
of the abdomen and pelvis every 2-5 years, yearly mammogram and endometrial biopsy every
3-5 years in women over 50 years of age <sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>The diagnosis of MTS is eminently clinical, corroborated by exams such as
immunohistochemistry and molecular analysis. Since the first publications reporting the
detection of repairing enzymes through the immunohistochemical method, loss of
<italic>MLH1</italic> and <italic>MSH2</italic> expression was observed in colorectal
carcinomas with microsatellite instability. Despite the micro-satellite instability
detected through PCR remaining as standard methodology, the employment of
immunohistochemistry in literature has expanded. <sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Analogous to this, the immunohistochemical study with antibodies against repair proteins
<italic>MSH2</italic>, <italic>MLH1</italic> and <italic>MSH6</italic> is currently
the accepted method for evaluation of the function of these proteins in sebaceous
neoplasms. The lack of nuclear immunoreactivity in tumor cells suggests MTS and has
shown good correlation of this finding with microsatellite instability when compared to
gold-standard tests. <sup><xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>Mathiak <italic>et al</italic> emphasize that the repair enzymes express themselves
properly in sporadic cases of sebaceous carcinoma, which reinforces even further the
role of immunohistochemistry in the characterization of MTS.<sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>Therefore, immunohistochemistry presents applicability in clinical practice as an
element of identification of neoplasms, which carry deficiency in the activity of repair
enzymes and phenotype of microsatellite instability. It is outstanding for MTS
confirmation, as it is more accessible and less costly than molecular analysis, allied
to its high positive predictive value. <sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>When suspicious of MTS, the dermatologist may proceed with an immunohistochemical study
of sebaceous tumors, if molecular analysis is not available to confirm the disease, thus
allowing secondary prevention of visceral tumors. In our case, the absence of repair
enzymes <italic>MSH2</italic> and <italic>MSH6</italic> in the immunohistochemical study
reiterated the diagnosis of MTS and triggered a series of propedeutic actions, aiming
for early diagnosis of morbidities and genetic counseling.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>How to cite this article:</bold> Oliveira CMPB, Campos JC, Maia MR, Lobo LES,
Valle FF. The role of immunohistochemistry in the Muir-Torre Syndrome. An Bras
Dermatol. 2015;90 (3 Suppl 1):168-70.</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Work performed at Hospital Universit&#xE1;rio Get&#xFA;lio Vargas - Universidade Federal do
Amazonas (HUGV-UFAM) and Funda&#xE7;&#xE3;o Centro de Controle de Oncologia do Estado do
Amazonas - Manaus (AM), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muir</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Multiple primary carcinomata of the colon, duodenum, and larynx
associated with keratoacanthomata of the face</article-title>
          <source>Br J Surg</source>
          <year>1967</year>
          <volume>54</volume>
          <fpage>191</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">6020987</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torre</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Multiple sebaceous tumors</article-title>
          <source>Arch Dermatol</source>
          <year>1968</year>
          <volume>98</volume>
          <fpage>549</fpage>
          <lpage>551</lpage>
          <pub-id pub-id-type="pmid">5684233</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Torre</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>The Muir-Torre syndrome: a 25-year retrospect</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1995</year>
          <volume>33</volume>
          <fpage>90</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">7601953</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ponti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ponz de Leon</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Review: Muir-Torre syndrome</article-title>
          <source>Lancet Oncol</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>980</fpage>
          <lpage>987</lpage>
          <pub-id pub-id-type="pmid">16321766</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tavakkol</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Furmanczyk</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Germline mutation in MSH6 associated with multiple malignant neoplasms
in a patient with Muir-Torre syndrome</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <fpage>e195</fpage>
          <lpage>e198</lpage>
          <pub-id pub-id-type="pmid">22734033</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mathiak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>R&#xFC;tten</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mangold</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Ruzicka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Friedl</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of DNA mismatch repair proteins in skin tumors from patients with
Muir-Torre syndrome and MSH2 e MLH1 germline mutations: Establishment of
immunohistochemical analysis as a screening test</article-title>
          <source>Am J Surg Pathol</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>338</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="pmid">11859205</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lind</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Sebaceous neoplasms with mismatch repair protein expressions and the
frequency of co-existing visceral tumors</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2012</year>
          <volume>67</volume>
          <fpage>1228</fpage>
          <lpage>1234</lpage>
          <pub-id pub-id-type="pmid">22552002</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shalin</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Lyle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Calonje</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lazar</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Sebaceous neoplasia and the Muir-Torre syndrome: important connections
with clinical implications</article-title>
          <source>Histopathology</source>
          <year>2010</year>
          <volume>56</volume>
          <fpage>133</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">20055911</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsalis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Blouhos</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vasiliadis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tsachalis</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Angelopoulos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Betsis</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Sebaceous gland tumors and internal malignancy in the context of
Muir-Torre syndrome. A case report and review of the literature</article-title>
          <source>World J Surg Oncol</source>
          <year>2006</year>
          <volume>4</volume>
          <fpage>8</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">16466577</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ko</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Muir-Torre syndrome: facts and controversies</article-title>
          <source>Clin Dermatol</source>
          <year>2010</year>
          <volume>28</volume>
          <fpage>324</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="pmid">20541687</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
